Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001)

K-Number: K243840 · 2025-03-26

ApplicantBridge TO Life
Decision Date2025-03-26
Product CodeKDN
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001) is a medical device manufactured by Bridge TO Life. It received FDA 510(k) clearance on 2025-03-26 under approval number K243840. The device is classified under product code KDN. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001)?

Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001) is a medical device that received FDA 510(k) clearance on 2025-03-26. It is manufactured by Bridge TO Life. The 510(k) number is K243840.

When was Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001) approved by the FDA?

Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001) received FDA 510(k) clearance on 2025-03-26, under approval number K243840.

What company makes Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001)?

Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001) is manufactured by Bridge TO Life.

What is the FDA product code for Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001)?

The FDA product code for Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001) is KDN.

Related Clinical Trials

NCT07606729 AI-Driven Programs for Non-specific Chronic Neck Pain ACTIVE_NOT_RECRUITING NCT07595627 Hypothermic Machine Perfusion for Liver Graft Preservation NOT_YET_RECRUITING NCT07224464 The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. RECRUITING NCT07585890 Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe RECRUITING NCT05574361 Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA) ACTIVE_NOT_RECRUITING NCT06485596 HOPE at Heart (HOPE) of Donor Hearts After Circulatory Death (DCD) Using the XVIVO Heart Assist Transport System. ACTIVE_NOT_RECRUITING

Other Devices by Bridge TO Life

K243618EasiSlush® Sodium Chloride Solution for Sterile Slush Preparation (BTLE-1250) K243384Belzer UW® Cold Storage Solution (BTLBUW-001)

Related Devices (Code: KDN)

K153384Low Potassium Dextran Solution with Tris DiluentUnited Therapeutics Corporation K180481Servator B SALF SolutionS.A.L.F. Spa K170826Perfadex PlusXvivo Perfusion AB K191440Paragonix SherpaPak Pancreas Transport SystemParagonix Technologies K191006EasiSlushBridge TO Life, Ltd. K201048SherpaPak Pediatric Liver Transport SystemParagonix Technologies

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑